Press Release

Global Neurovascular Devices Market Projected to Hit USD6.5 Billion Mark by 2030

The Global Neurovascular Devices Market size was valued at around USD3.9 billion in 2024 and is projected to reach USD6.5 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 8.6% during the forecast period, i.e., 2025-30, cites MarkNtel Advisors in the recent research report. The demand for neurological devices is growing due to the rising aging population and increased government initiatives on neurological diseases. For instance, the WHO projects that by 2030, 1 in every 6 people will be aged 60 or above. Growing older is a higher risk factor for neurological disorders such as Alzheimer's and stroke. The increasing prevalence of such types of diseases is a major cause to invent novel neurovascular and neurostimulation devices that would be significantly effective for management and treatment. On this point, health systems are investing in high-tech devices for the enhancement of diagnostic accuracy and treatment of the disease condition. In addition, increased awareness and easy access to health services are popularizing the use of neurological devices, thereby surging demand in the market.

There is pressure on the governments of the world to enhance research, which is channeled into the enhancement of neurological diseases, thereby increasing the use of neurovascular devices. For instance, in 2023, the U.S. National Institute on Aging allocated 4 billion US dollars for the research and treatment of neurological conditions such as Alzheimer's, Parkinson's, and stroke. They promote technology as research helps develop better diagnostic and therapeutic tools for the benefit of improving the patient's welfare. Similarly, India's National Programme for Non-Communicable Diseases aims to improve the quality of managing neurological disorders through the proper use of diagnostic techniques and neurovascular devices for their treatment, further states the research report, Global Neurovascular Devices Market Analysis, 2025.”

Global Neurovascular Devices Market Segmentation Analysis

Hospitals Generating Huge Demand for Neurovascular Devices

Based on end-user, the market is segmented into hospitals, specialty clinics, and others. Among these hospital segment holds the largest market share, around 60%. This can be attributed to the increasing number of patients in the hospital, as it remains the primary site of diagnosis, treatment, and intervention for neurological illnesses. Hospitals are ready with advanced technology and skilled specialists to provide complete care. Neurologists collaborate with different departments or specialists to develop personalized remedial plans for patients. Consequently, the provision of minimally invasive surgery complements the achievement rate of hospitals due to advanced technologies used in the treatment of cranial situations and tumors, and consequently, will increase clinic demand over the coming years.

North America Driving Global Neurovascular Devices Market

North America occupied the largest share of the market, about 43.15%. North America leads the market because of the aging population and more developed health infrastructure. For instance, according to the National Brain Tumor Society, in 2022, about 94,390 people were living with brain tumors in the United States. Additionally, one has a stroke every 40 seconds, while one dies from a stroke every 3 minutes to 11 seconds. Alarming causes of serious concern and rising incidence of brain tumors in America are the advances in technology and an increase.

The major manufacturers present in the region propel the demand for neurovascular disease treatment, such as Stryker Corporation, Johnson & Johnson, and Phenox Inc. In 2023, pRESET thrombectomy devices were granted FDA clearance for use in the treatment of acute ischemic stroke in the United States. Therefore, the growing prevalence of neurological disorders and the ever-growing demand for surgical procedures drive the North America Neurovascular Device Market.

 Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market players, Asahi Intecc, Neuronetics, Medtronic, Sahajanand Medical Technologies, MicroVention, Acandis, Abbott Laboratories, Cerenovus, Boston Scientific, Vascular, Johnson and Johnson, Neuravi, Stryker, Penumbra Terumo, Philips Healthcare, and others. And others are the top players in the Global Neurovascular Devices Market., Others are looking forward to strengthening their market position.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- by Value, Forecast Numbers, Segmentation, and Shares)?
2. What are the trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the globe?
4. How has the industry been evolving in terms of geography and product adoption?
5. How has the competition been shaping up across various regions?
6. How have buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2020-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?